Eli Lilly (LLY) Equity Ratio (2016 - 2025)
Eli Lilly's Equity Ratio history spans 17 years, with the latest figure at 0.24 for Q4 2025.
- For Q4 2025, Equity Ratio rose 30.12% year-over-year to 0.24; the TTM value through Dec 2025 reached 0.24, up 30.12%, while the annual FY2025 figure was 0.24, 30.12% up from the prior year.
- Equity Ratio reached 0.24 in Q4 2025 per LLY's latest filing, up from 0.21 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.24 in Q4 2025 to a low of 0.09 in Q1 2022.
- Average Equity Ratio over 5 years is 0.04, with a median of 0.0 recorded in 2024.
- Peak YoY movement for Equity Ratio: crashed 1792.12% in 2022, then surged 5819.72% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.0 in 2021, then tumbled by 1792.12% to 0.06 in 2022, then surged by 286.05% to 0.11 in 2023, then skyrocketed by 60.07% to 0.18 in 2024, then surged by 30.12% to 0.24 in 2025.
- Per Business Quant, the three most recent readings for LLY's Equity Ratio are 0.24 (Q4 2025), 0.21 (Q3 2025), and 0.02 (Q2 2025).